Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

Fig. 6

"ZLJT-compound-target-disease" network. A link represents the interaction between a compound and a target node. The small circle indicates target proteins. The large circle indicates active compounds; orange represents Huangqi, green represents Danggui, red represents Baiying, brown represents Longkui, pink represents Danshen, purple represents Shemei, blue represents Banzhilian, and yellow represents Yujin

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us